EUVIMEDEUVIMED entdecken
Crossref

Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation

Enrico Poletti, Ole De Backer, Andrea Scotti, Giuliano Costa, Francesco Bruno, Claudia Fiorina, Nicola Buzzatti, Alessia Latini, Tanja K Rudolph, Mark M P van den Dorpel, Christina Brinkmann, Kush P Patel und 15 weitere

JACC: Cardiovascular Interventions · 2023-08 · 16 (16) · 1974-1985

DOI: 10.1016/j.jcin.2023.07.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2023-08. Verfasst von Enrico Poletti und 26 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Interventional Cardiology Department, IRCCS Policlinico San Donato, Milan, Italy. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Insufficiency. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transcatheter aortic valve replacement (TAVR) in patients with pure severe native aortic valve regurgitation (NAVR) has been associated with suboptimal results. The available evidence concerns mostly outdated transcatheter heart valves (THVs). OBJECTIVES: The aim of this study was to investigate the performance of new-generation THVs in patients treated for pure severe NAVR. METHODS: The PANTHEON (Performance of Currently Available Transcatheter Aortic Valve Platforms in Inoperable Patients With Pure Aortic Regurgitation of a Native Valve) study retrospectively included patients who underwent TAVR with currently available devices (both self-expanding [SE] and balloon expandable [BE]) for severe NAVR. Technical and device success rates as well as a composite of all-cause mortality and heart failure rehospitalization at 1 year were evaluated. The rate and clinical consequences of acute transcatheter valve embolization or migration (TVEM) were also considered. RESULTS: A total of 201 patients were included. Overall technical and device success rates were 83.6% and 76.1%, respectively, and did not differ between SE and BE devices. These figures were due mostly to TVEM occurrence (14.6% vs 16.1%; P = 0.47) and residual moderate or greater aortic regurgitation (9.2% vs 10.1%; P = 0.87). Patients who experienced TVEM compared with those without TVEM had a significantly higher incidence of the composite endpoint at 1 year (25.7% vs 15.8%; P = 0.05). CONCLUSIONS: Despite improved THV platforms and techniques, TAVR for pure severe NAVR remains a challenging procedure, with significant risk for TVEM. SE and BE platforms demonstrated comparable performance in this setting. (Performance of Currently Available Transcatheter Aortic Valve Platforms in Inoperable Patients With Pure Aortic Regurgitation of a Native Valve [PANTHEON]; NCT05319171).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve InsufficiencyHumansAortic ValveRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

pure native aortic regurgitationtranscatheter aortic valve replacementtranscatheter valve embolization

Autor:innen und Institutionen

  • Clinical and Interventional Cardiology Department, IRCCS Policlinico San Donato, Milan, Italy.
  • Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Division of Cardiology, CAST, Azienda Ospedaliero - Universitaria Policlinico G. Rodolico - San Marco, University of Catania, Catania, Italy.
  • Department of Cardiology, Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, Harefield Hospital, Harefield, United Kingdom.
  • Spedali Civili Brescia, Brescia, Italy.

Zitieren

APA

Poletti, E., De Backer, O., Scotti, A., Costa, G., Bruno, F., Fiorina, C., Buzzatti, N., Latini, A., Rudolph, T. K., van den Dorpel, M. M. P., Brinkmann, C., Patel, K. P., Panoulas, V., Schofer, J., Giordano, A., Barbanti, M., Regazzoli, D., Taramasso, M., Saia, F., …, & Testa, L. (2023). Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation. JACC: Cardiovascular Interventions, 16(16), 1974-1985. https://doi.org/10.1016/j.jcin.2023.07.026

Vancouver

Poletti E, De Backer O, Scotti A, Costa G, Bruno F, Fiorina C, et al. Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation. JACC: Cardiovascular Interventions. 2023;16(16):1974-1985. doi:10.1016/j.jcin.2023.07.026

BibTeX
@article{Poletti2023,
  author = {Poletti, Enrico and De Backer, Ole and Scotti, Andrea and Costa, Giuliano and Bruno, Francesco and Fiorina, Claudia and Buzzatti, Nicola and Latini, Alessia and Rudolph, Tanja K and van den Dorpel, Mark M P and Brinkmann, Christina and Patel, Kush P and Panoulas, Vasileios and Schofer, Joachim and Giordano, Arturo and Barbanti, Marco and Regazzoli, Damiano and Taramasso, Maurizio and Saia, Francesco and Baumbach, Andreas and Maisano, Francesco and Van Mieghem, Nicolas M and Søndergaard, Lars and Latib, Azeem and Amat Santos, Ignacio J and Bedogni, Francesco and Testa, Luca},
  title = {Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation},
  journal = {JACC: Cardiovascular Interventions},
  year = {2023},
  volume = {16},
  number = {16},
  pages = {1974--1985},
  doi = {10.1016/j.jcin.2023.07.026}
}
Kostenlos starten →